Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results.

Blood
I F KhouriHomer A Macapinlac

Abstract

In 2008, we reported favorable 5-year outcomes of nonmyeloablative allogeneic stem cell transplantation after fludarabine, cyclophosphamide, rituximab (FCR) conditioning for relapsed and chemosensitive follicular lymphoma. However, innovative strategies were still needed to treat patients with chemorefractory disease. We therefore subsequently performed a trial in which (90)Y-ibritumomab tiuxetan (0.4 mCi/kg) was added to the fludarabine, cyclophosphamide conditioning regimen ((90)YFC). Here, we report updated results of the FCR trial and outcomes after (90)YFC. For the FCR group (N = 47), since the last update, one patient developed recurrent disease. With a median follow-up of 107 months (range, 72-142 months), the 11-year overall survival and progression-free survival rates were 78%, and 72%, respectively. For the (90)YFC group (N = 26), more patients had chemorefractory disease than did those in the FCR group (38% and 0%, P < .001). With a median follow-up of 33 months (range,17-94 months), the 3-year progression-free survival rates for patients with chemorefractory and chemosensitive disease were 80% and 87%, respectively (P = .7). The low frequency of relapse observed after a long follow-up interval of 9 years in the FCR ...Continue Reading

References

Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B D ChesonG P Canellos
Mar 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas E WitzigPratik S Multani
Apr 19, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C HosingI F Khouri
Jun 13, 2003·Oncology·Leona A Holmberg, F Marc Stewart
Apr 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Issa F KhouriRichard E Champlin
Dec 13, 2005·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Alexandra H FilipovichMary E D Flowers
Jan 24, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonUNKNOWN International Harmonization Project on Lymphoma
May 5, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marinus H J van OersAnton Hagenbeek
May 28, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Sally F BarringtonMichael J O'Doherty
Nov 16, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Marcie R TomblynGinna G Laport

❮ Previous
Next ❯

Citations

Jan 25, 1979·Biochimica Et Biophysica Acta·D P JonesH S Mason
Apr 3, 2013·Nature Reviews. Clinical Oncology·James N Kochenderfer, Steven A Rosenberg
May 25, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F BucheggerN Ketterer
Oct 10, 2013·Current Opinion in Hematology·Andrew R Rezvani, Brenda M Sandmaier
May 28, 2013·Bone Marrow Transplantation·E KlyuchnikovT S Fenske
Apr 6, 2013·Immunotherapy·Joseph G Jurcic
Jun 20, 2014·Journal of Clinical and Experimental Hematopathology : JCEH·Sung Won Kim
Oct 31, 2015·Expert Opinion on Biological Therapy·V R Bhatt, J O Armitage
Dec 3, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Ryan D CassadayAjay K Gopal
Dec 22, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Issa F Khouri
Oct 17, 2015·Annual Review of Medicine·Krishna V Komanduri, Ross L Levine
Oct 16, 2012·Blood Reviews·Matthew A Lunning, Julie M Vose
Jul 22, 2015·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Fei ChenXun Lai
Mar 18, 2016·Current Hematologic Malignancy Reports·Vijaya Raj Bhatt
Sep 22, 2015·Current Opinion in Hematology·Nicoletta CieriPaolo Corradini
May 13, 2015·Future Oncology·Patrick M Reagan, Jonathan W Friedberg
Feb 6, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Mehdi HamadaniHillard M Lazarus
Apr 27, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Mohamed A Kharfan-DabajaMehdi Hamadani
Mar 19, 2016·Blood·Brad S Kahl, David T Yang
Apr 28, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Ginna G LaportUNKNOWN Blood and Marrow Transplant Clinical Trials Network
May 2, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Timothy S FenskeChristopher Bredeson
Jul 30, 2016·Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine·Jew Win KuanKian Meng Chang
Aug 20, 2016·Expert Review of Hematology·Saveria CapriaAlessandro Pulsoni
Feb 2, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Denise M OlianskyTheresa Hahn
Apr 4, 2017·Bone Marrow Transplantation·M A Kharfan-DabajaM Hamadani
Dec 7, 2018·Hematology·Christopher R FlowersLoretta J Nastoupil
Dec 13, 2017·Journal of Oncology Practice·Mehdi Hamadani, Mary M Horowitz
Apr 14, 2017·The New England Journal of Medicine·Ephraim P HochbergAbner Louissaint
Dec 7, 2019·Hematology·Victor A Chow, Ajay K Gopal
Jan 13, 2021·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nirav N Shah, Mehdi Hamadani
Jan 9, 2021·Frontiers in Oncology·Scott R GoldsmithJohn F DiPersio

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.